Effect of reduction in ciprofloxacin use on prevalence of meticillin-resistant Staphylococcus aureus rates within individual units of a tertiary care hospital
- 31 December 2006
- journal article
- research article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 64 (4) , 348-351
- https://doi.org/10.1016/j.jhin.2006.06.033
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antimicrobial Drug Use and Methicillin-resistantStaphylococcus aureus, Aberdeen, 1996–2000Emerging Infectious Diseases, 2004
- Antimicrobial Resistance Trends and Outbreak Frequency in United States HospitalsClinical Infectious Diseases, 2004
- Fluoroquinolones and the Risk for Methicillin-resistantStaphylococcus aureusin Hospitalized Patients1Emerging Infectious Diseases, 2003
- Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobialsJournal of Antimicrobial Chemotherapy, 2002
- Antimicrobial-Drug Use and Methicillin-Resistant Staphylococcus aureusEmerging Infectious Diseases, 2001
- Induction of Fibronectin-Binding Proteins and Increased Adhesion of Quinolone-ResistantStaphylococcus aureusby Subinhibitory Levels of CiprofloxacinAntimicrobial Agents and Chemotherapy, 2000
- Antibiotic resistance in Gram-positive bacteria: epidemiological aspectsJournal of Antimicrobial Chemotherapy, 1999
- Methicillin-Resistant Staphylococcus Aureus and Antimicrobial Use in Belgian HospitalsInfection Control & Hospital Epidemiology, 1999
- Antibiotic usage and methicillin-resistant Staphylococcus aureus: an analysis of causality.Journal of Antimicrobial Chemotherapy, 1998
- Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidisThe Lancet, 1997